title: Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin.
authors: The University of Texas School of Public Health, Kelsey Research Foundation, Baylor College of Medicine, Baylor St. Luke's Medical Center, Houston, Texas, USA Herbert.L.Dupont@uth.tmc.edu.
authors: Herbert L
authors: HL
authors: DuPont
authors: Salix Pharmaceuticals, Raleigh, North Carolina, USA.
authors: Ray A
authors: RA
authors: Wolf
authors: Salix Pharmaceuticals, Raleigh, North Carolina, USA.
authors: Robert J
authors: RJ
authors: Israel
authors: Cedars-Sinai Medical Center, Los Angeles, California, USA.
authors: Mark
authors: M
authors: Pimentel
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003967:Diarrhea / Q000188:drug therapy* / Q000382:microbiology*; D004334:Drug Administration Schedule; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000188:drug therapy* / Q000382:microbiology*; D012294:Rifamycins / Q000627:therapeutic use*; D000078262:Rifaximin; D012867:Skin / Q000382:microbiology*; D013210:Staphylococcus / Q000187:drug effects*
chemical_list: D000890:Anti-Infective Agents; D012294:Rifamycins; D000078262:Rifaximin
keywords: antibiotics; irritable bowel syndrome with diarrhea; resistance; rifaximin; skin swabs; staphylococcal isolates; susceptibility